Browse Intravenous therapy topic

Subtopics (7) Educational aspects Equipment and supplies Health aspects Licensing, certification and accreditation Management Methods Usage

Articles 1-38 out of 38 article(s) Title Author Type Date Words Education is similar to that for IV chemotherapy. Jones, Debra A. Brief article Aug 1, 2008 133 Whitaker effectively treats Parkinson's with IV-glutathione at Whitaker Wellness Institute. Gerson, Charlotte Jan 1, 2007 339 Standardising intravenous therapy competencies. Culverwell, Elizabeth Oct 1, 2006 306 Specialized Health Products International, Inc. Brief Article Jun 1, 2005 49 New tool avoids sticking patients 10-15 times. (Tech Watch). Jul 1, 2003 716 Save $100,000 by using saline locks instead of IVs. (Cost-Saving Tip). May 1, 2003 388 NY: surgery patient injured by I.V. in hand: court held Res Ipsa Loquitur applied. (Medical Malpractice Cases). Tammelleo, David A. Sep 1, 2002 561 Fayetteville pharmacy partners with home I.V. (Nw Journal). Butler, Elisabeth Brief Article Mar 4, 2002 202 OH: Surgery Pt. Passes Plastic I.V. Cap Vaginally: Was Res Ipsa Loquitur Doctrine Applicable? Tammelleo, A. David Brief Article Jul 1, 2001 414 Sharps Disposal Containers. Brief Article Dec 1, 2000 115 Bigmar Announces 1999 First Quarter Results. May 18, 1999 607 BIGMAR Commences Proprietary Drug Development Strategy Via Licensing and Supply Agreement With Graminex. May 4, 1999 534 Bigmar Featured in Forbes ASAP Magazine's Fast 500 List. Apr 5, 1999 359 Bigmar Announces 1998 Results. Apr 1, 1999 671 BIGMAR Receives FDA Approval for Fluorouracil Injection; Sixth ANDA Approval in 1999. Mar 29, 1999 503 Bigmar Receives Product Approvals From the FDA. Mar 1, 1999 486 BIGMAR Signs Distribution Agreement With Antigen Pharmaceuticals. Feb 18, 1999 234 BIGMAR's Manufacturing Facility Inspected by FDA. Feb 12, 1999 194 Bigmar, Inc. Signs Distribution Agreements. Jan 28, 1999 192 BIGMAR, Inc. Discusses Restructuring Convertible Debt; Receives Compliance Notice From NASDAQ. Dec 18, 1998 214 BIGMAR, Inc. Receives Suitability Petition Approval From FDA to File ANDA for Dacarbazine. Dec 7, 1998 329 Bigmar, Inc. Announces Third Quarter Results. Nov 17, 1998 561 Bigmar, Inc. Receives Blanket Authorization To Manufacture and Market Injectible Pharmaceutical Products From Swiss Regulatory Authorities. Oct 7, 1998 276 Alaris Medical Raises Approximately $109 Million in Private Placement Offering. Article Jul 29, 1998 505 XOMA'S Neuprex Receives Orphan Drug Designation for the Treatment of Severe Meningococcal Disease. Article Jun 23, 1998 832 Pediatric Services of America, Inc. Acquires New Jersey Infusion Companies and Missouri Pediatric Physical Therapy Company. Nov 10, 1997 344 Alaris Medical Inc. survives a feast of changes. Acello, Richard Oct 27, 1997 756 Ivax Corp.'s 'BB+' Corp Credit Rtg Remains on S&PWatch, Neg. Jun 25, 1997 162 Apria Healthcare Group Inc. reports first quarter results; EPS of $0.37 in line with analysts' consensus estimates. Apr 30, 1997 593 Cancer Treatment Holdings Inc. announces stock buyback program. Apr 24, 1997 136 Bigmar announces initial public offering. Jun 20, 1996 321 Infu-Tech names Pennessi to new post. May 31, 1996 310 Infu-Tech reports third quarter/nine months results. Apr 30, 1996 432 RAPID EXPANSION OF HOME CARE MARKET TO DRIVE IV THERAPY DEVICES MARKET. Mar 6, 1996 521 Coram completes purchase of Caremark's home IV therapy business. Apr 6, 1995 175 CTH announces record results for the second quarter of fiscal 1995. Jan 24, 1995 360 Intermittent intravenous therapy: a comparison of two flushing solutions. Robertson, Jeanette Report Dec 1, 1994 2725 Coram Healthcare announces appointment of director. Nov 7, 1994 295